We are investigating the molecular mechanisms underlying age-related macular degeneration (AMD), with a particular focus on the role of retrotransposons in retinal pigment epithelium (RPE) degeneration. Our goal is to uncover novel insights that will pave the way for the development of targeted therapeutics to protect against or delay the progression of AMD and prevent vision loss.